Tag

NASDAQ: RARE

Ultragenyx Pharmaceutical agrees to US$203M priority review voucher sale
Theo Marchetti · Oct 14, 2026
Ultragenyx Pharmaceutical agrees to sell rare pediatric voucher for US$210M
Adrian Kessler · Oct 8, 2026
Ultragenyx says EMA validates Sanfilippo gene therapy application
Adrian Kessler · Oct 3, 2026